Latest News and Press Releases

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments - What to Consider Training Course (Mar 23rd - Mar...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "EU (European Union) Pharmaceutical Regulations & Strategy Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ...

LAS VEGAS, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Expanse Studios, the gaming content subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), announced it will launch its proprietary game portfolio in...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Training Course (Mar 5th - Mar 6th, 2026)" training has been added to ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (“BRW” or the...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Project Management for Pharma Professionals Training Course (Mar 9th - Mar 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. ...

50MW data center estimated enterprise value of ~$500MM LAS VEGAS, NV, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Jet.AI Inc. (NASDAQ: JTAI) (“Jet.AI” or the “Company”), an emerging provider of...

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects (May 11, 2026)" training has been added to ResearchAndMarkets.com's...

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of...